Dr. Reddy’s Laboratories has a total of 4592 patents globally, out of which 1125 have been granted. Of these 4592 patents, more than 40% patents are active. India is where Dr. Reddy’s Laboratories has filed the maximum number of patents, followed by USA and Europe. Parallelly, India seems to be the main focused R&D center and is also the origin country of Dr. Reddy’s Laboratories.
Dr. Reddy’s Laboratories was founded in 1984 by Kallam Anji Reddy. Dr. Reddy’s Laboratories provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world. As of April 2022, Dr. Reddy’s Laboratories has a market cap of $9.49 Billion.
Do read about some of the most popular patents of Dr. Reddy’s Laboratories which have been covered by us in this article and also you can find Dr. Reddy’s Laboratories patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Dr. Reddy’s Laboratories patent portfolio.
How many patents does the Founder and CEO of Dr. Reddy’s Laboratories have?
The Founder Kallam Anji Reddy has 21 patents and the CEO, Erez Israeli has 0 patents.
How many patents does Dr. Reddy’s Laboratories have?
Dr. Reddy’s Laboratories has a total of 4592 patents globally. These patents belong to 1742 unique patent families. Out of 4592 patents, 1866 patents are active.
How Many Patents did Dr. Reddy’s Laboratories File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Dr. Reddy’s Laboratories Applications Filed | Dr. Reddy’s Laboratories Patents Granted |
| 2011 | 236 | 34 |
| 2012 | 207 | 30 |
| 2013 | 207 | 19 |
| 2014 | 302 | 35 |
| 2015 | 275 | 50 |
| 2016 | 372 | 54 |
| 2017 | 234 | 54 |
| 2018 | 237 | 109 |
| 2019 | 221 | 81 |
| 2020 | 106 | 63 |
| 2021 | 58 | 100 |
| 2022 | 4 | 24 |
How many Dr. Reddy’s Laboratories patents are Alive/Dead?
Worldwide Patents
Patent Families
How Many Patents did Dr. Reddy’s Laboratories File in Different Countries?
Countries in which Dr. Reddy’s Laboratories Filed Patents
| Country | Patents |
| India | 972 |
| United States Of America | 680 |
| Europe | 367 |
| Australia | 203 |
| Japan | 168 |
| China | 155 |
| Canada | 148 |
| Brazil | 109 |
| Korea (South) | 96 |
| Mexico | 89 |
| Germany | 87 |
| Israel | 86 |
| Russia | 69 |
| New Zealand | 59 |
| Singapore | 59 |
| Hong Kong (S.A.R.) | 51 |
| Eurasia | 47 |
| South Africa | 44 |
| Austria | 40 |
| Spain | 36 |
| Malaysia | 36 |
| Poland | 31 |
| Hungary | 29 |
| Croatia | 28 |
| Philippines | 28 |
| Indonesia | 26 |
| Cuba | 23 |
| Denmark | 22 |
| Colombia | 16 |
| Czech Republic | 15 |
| Ukraine | 15 |
| Portugal | 15 |
| Serbia | 14 |
| Norway | 13 |
| Slovenia | 11 |
| United Kingdom | 11 |
| Lithuania | 9 |
| Albania | 9 |
| Taiwan | 8 |
| Turkey | 8 |
| Argentina | 8 |
| Bulgaria | 7 |
| Slovakia | 7 |
| Viet Nam | 6 |
| Estonia | 6 |
| Cyprus | 5 |
| Chile | 5 |
| Kazakhstan | 4 |
| Yugoslavia/Serbia and Montenegro | 4 |
| Macao | 3 |
| Romania | 2 |
| Africa | 1 |
| San Marino | 1 |
| Ecuador | 1 |
| Jordan | 1 |
| Saudi Arabia | 1 |
| Republic of Moldova | 1 |
| Finland | 1 |
| Peru | 1 |
| Belarus | 1 |
| Morocco | 1 |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
| Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
| US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
| US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
Where are the Research Centers of Dr. Reddy’s Laboratories Patents Located?
10 Best Dr. Reddy’s Laboratories Patents
WO2015033299A1 is the most popular patent in Dr. Reddy’s Laboratories portfolio. It has received 193 citations so far from companies like Idorsia Pharmaceuticals, Gilead Sciences and Genentech Inc.
Below is the list of 10 most cited patents of Dr. Reddy’s Laboratories:
| Publication Number | Citation Count |
| WO2015033299A1 | 193 |
| WO2015033301A1 | 163 |
| WO2012168944A1 | 160 |
| US8907053B2 | 148 |
| WO2015044900A1 | 135 |
| WO2013144704A1 | 133 |
| WO2013042137A1 | 131 |
| WO2015104662A1 | 117 |
| WO2003033481A1 | 114 |
| WO2002062799A1 | 113 |
Which Companies are using Dr. Reddy’s Laboratories Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Dr. Reddy’s Laboratories patent portfolio are Mylan Laboratories Limited, Wellesley Pharmaceuticals Llc and Cadila Healthcare.
List of the top forward citing Companies –
| Company | Number of Patents |
| Mylan Laboratories Limited | 5 |
| Wellesley Pharmaceuticals Llc | 5 |
| Cadila Healthcare | 4 |
| Scinopharm Taiwan Ltd | 4 |
| Innopharma Inc | 4 |
| Sun Pharmaceutical Industries Ltd | 4 |
| Novartis | 3 |
| Ranbaxy Laboratories | 3 |
| Pharmachem Laboratories Llc | 3 |
| Hercules Llc | 3 |
Count of 102 and 103 Type Rejections based on Dr. Reddy’s Laboratories Patents
Top Dr. Reddy’s Laboratories Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US7541445B2 | 7 |
| US20070141150A1 | 6 |
| US20050107612A1 | 5 |
| US20050026992A1 | 5 |
| US20090263475A1 | 5 |
| US20050042277A1 | 5 |
| US20110236475A1 | 5 |
| US20090281136A1 | 4 |
| US7889675B2 | 4 |
| US20100048598A1 | 4 |
| US20050147663A1 | 4 |
| US8431140B2 | 4 |
| US20090263481A1 | 4 |
| US20110009362A1 | 4 |
| US20110201631A1 | 3 |
What Percentage of Dr. Reddy’s Laboratories US Patent Applications were Granted?
Dr. Reddy’s Laboratories (Excluding its subsidiaries) has filed 541 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 222 have been granted leading to a grant rate of 45.03%.
Below are the key stats of Dr. Reddy’s Laboratories patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Dr. Reddy’s Laboratories?
| Law Firm | Total Applications | Success Rate |
| Dr Reddy S Laboratories Inc | 260 | 30.00% |
| Pergament & Cepeda Llp | 138 | 42.74% |
| Stites & Harbison Pllc | 27 | 78.26% |
| Reddy Us Therapeutics Inc | 24 | 77.27% |
| Ladas & Parry | 21 | 70.00% |
| Lerner David Littenberg | 14 | 85.71% |
| Sullivan Ip Solutions Llc | 12 | 100.00% |
| Janet I Cord | 7 | 85.71% |
| Mrg Upsher Smith Laboratories Llc | 6 | 100.00% |
| Womble Bond Dickinson Us Llp | 6 | 100.00% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Dr. Reddy’s Laboratories key innovation segments?